Skip to main content
. 2016 Jan 18;6:19288. doi: 10.1038/srep19288

Figure 3. Isorhamnetin reduces body weight, insulin resistance and serum lipid level in DIO mice.

Figure 3

(a) Body weight. (b) Food intake amount. (c) Fecal triglyceride level. (d) Body temperature. (e) The mass of white adipose tissue. (f) Fasting blood glucose level. (g) Glucose tolerance test (GTT). The area under the curve (AUC) was calculated from the GTT graph. (h) Insulin tolerance test (ITT). The area under the curve (AUC) was calculated from the ITT graph. (i) Serum insulin level. (j) Serum leptin level. (k) Serum adiponectin level. (l) Serum TC, TC, LDL-c and HDL-c. (m) Plasma free fatty acid (FFA) levels. The mice were treated for 4 weeks. IR: isorhamnetin. Data are presented as means ± SEM (n = 8). *P < 0.05, **P < 0.01. NS: No significance.